triazoles has been researched along with Age-Related Memory Disorders in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (4.17) | 18.2507 |
| 2000's | 8 (33.33) | 29.6817 |
| 2010's | 13 (54.17) | 24.3611 |
| 2020's | 2 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Babaei, P; Badrikoohi, M; Esmaeili-Bandboni, A | 1 |
| Alves, D; Fronza, MG; Praticò, D; Sacramento, M; Savegnago, L | 1 |
| Alves, D; Baldinotti, R; Begnini, K; Collares, T; Dalberto, BT; Fronza, MG; Goldani, B; Kremer, FS; Lenardão, EJ; Martins, MC; Pinto, LDS; Savegnago, L; Seixas, FK | 1 |
| Apaijai, N; Chattipakorn, N; Chattipakorn, SC; Pintana, H | 1 |
| Almeida, AS; Botton, PH; Chenet, GC; Cunha, RA; Loss, CM; Marques, DM; Mioranzza, S; Nunes, F; Pagnussat, N; Porciúncula, LO | 1 |
| Crystal, JD; Hohmann, AG; Kulkarni, PM; Lai, YY; Smith, AE; Thakur, GA; Xu, Z | 1 |
| Akbarzadeh, T; Asatouri, R; Karimpour-Razkenari, E; Khanavi, M; Mahdavi, M; Moghadam, FH; Najafi, Z; Saeedi, M; Sharifzadeh, M; Vafadarnejad, F | 1 |
| Agostinho, PM; Cognato, GP; Cunha, RA; Hockemeyer, J; Müller, CE; Souza, DO | 1 |
| Canas, PM; Cunha, GM; Cunha, RA; Machado, NJ; Oliveira, CR; Oliveira, JM; Porciúncula, LO; Silva, CG | 1 |
| Abbatecola, AM; D'Amico, M; Di Filippo, C; Ferraraccio, F; Marfella, R; Paolisso, G; Rossi, F | 1 |
| Arriza, JL; Castner, SA; Christian, EP; Mrzljak, L; Roberts, JC; Williams, GV | 1 |
| Crossley, M; Lejbak, L; Vrbancic, M | 1 |
| Brandão, R; Jesse, CR; Leite, MR; Nogueira, CW; Wilhelm, EA | 1 |
| Agostinho, PM; Canas, PM; Costenla, AR; Cunha, RA; de Mendonça, A; Diógenes, MJ; Maroco, J; Nogueira, C; Ribeiro, JA; Rodrigues, RJ | 1 |
| Aota, M; Doihara, H; Harada, K; Matsuoka, N; Morita, M; Nakato, K; Ni, K; Saita, K; Sato, Y; Takahashi, S; Yamaji, T; Yamazaki, M; Yarimizu, J | 1 |
| Bölcskei, K; Danysz, W; Dekundy, A; Dézsi, L; Gravius, A; Gyertyán, I; Hofmann, M; Horváth, C; Kordás, KS; Parsons, CG; Sághy, K; Wittko-Schneider, IM | 1 |
| Fallowfield, L; Howell, A; Hutton, S; Jenkins, V; Shilling, V | 1 |
| Ameye, L; Carbonez, A; Christiaens, MR; Morales, L; Neven, P; Paridaens, R; Timmerman, D; Van Huffel, S; Van Limbergen, E; Vergote, I | 1 |
| Ahmed, S; Amory, JK; Bremner, W; Cherrier, MM; Craft, S; Johnson, M; Matsumoto, AM; Peskind, ER; Raskind, MA | 1 |
| Fernandes, D; Prediger, RD; Takahashi, RN | 1 |
| Kamei, C; Masuoka, T; Mikami, A; Takiguchi, A; Yamamoto, Y | 1 |
| Fathollahi, Y; Moradpour, F; Naghdi, N | 1 |
| Canas, PM; Cunha, GM; Cunha, RA; Hockemeyer, J; Melo, CS; Müller, CE; Oliveira, CR | 1 |
| Hamm, RJ; O'Dell, DM | 1 |
3 trial(s) available for triazoles and Age-Related Memory Disorders
| Article | Year |
|---|---|
Does hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition? A pilot study.
Topics: Affect; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Anxiety; Breast Neoplasms; Cognition Disorders; Depression; England; Estrogens; Female; Humans; Memory Disorders; Memory, Short-Term; Middle Aged; Neuropsychological Tests; Nitriles; Personality Inventory; Pilot Projects; Reaction Time; Self-Assessment; Tamoxifen; Triazoles; Verbal Learning | 2004 |
Acute effects of tamoxifen and third-generation aromatase inhibitors on menopausal symptoms of breast cancer patients.
Topics: Anastrozole; Aromatase Inhibitors; Belgium; Body Mass Index; Breast Neoplasms; Data Interpretation, Statistical; Demography; Dyspareunia; Female; Hot Flashes; Humans; Letrozole; Logistic Models; Memory Disorders; Menopause; Middle Aged; Musculoskeletal Diseases; Nitriles; Pain; Patient Selection; Prospective Studies; Randomized Controlled Trials as Topic; Surveys and Questionnaires; Tamoxifen; Time Factors; Triazoles; Urination Disorders; Vaginal Diseases; Withholding Treatment | 2004 |
The role of aromatization in testosterone supplementation: effects on cognition in older men.
Topics: Aged; Aged, 80 and over; Aging; Anastrozole; Aromatase; Aromatase Inhibitors; Double-Blind Method; Estradiol; Humans; Male; Memory; Memory Disorders; Middle Aged; Neuropsychological Tests; Nitriles; Prostate-Specific Antigen; Spatial Behavior; Testosterone; Triazoles; Verbal Learning | 2005 |
21 other study(ies) available for triazoles and Age-Related Memory Disorders
| Article | Year |
|---|---|
Simultaneous administration of bromodomain and histone deacetylase I inhibitors alleviates cognition deficit in Alzheimer's model of rats.
Topics: Alzheimer Disease; Animals; Azepines; Behavior, Animal; Benzamides; CREB-Binding Protein; Disease Models, Animal; Drug Therapy, Combination; Epigenesis, Genetic; Histone Deacetylase Inhibitors; Male; Memory Disorders; Nuclear Proteins; Pyridines; Random Allocation; Rats; Rats, Wistar; Transcription Factors; Triazoles; Tumor Necrosis Factor-alpha | 2022 |
QTC-4-MeOBnE Ameliorated Depressive-Like Behavior and Memory Impairment in 3xTg Mice.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Depressive Disorder, Major; Disease Models, Animal; Hippocampus; Memory Disorders; Mice; Mice, Transgenic; Neuroinflammatory Diseases; tau Proteins; Triazoles | 2023 |
Rational design, cognition and neuropathology evaluation of QTC-4-MeOBnE in a streptozotocin-induced mouse model of sporadic Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Cognition; Disease Models, Animal; Male; Maze Learning; Memory Disorders; Mice; Molecular Docking Simulation; Neuroprotective Agents; Quinolines; Streptozocin; Triazoles | 2019 |
DPP-4 inhibitors improve cognition and brain mitochondrial function of insulin-resistant rats.
Topics: Adamantane; Animals; Behavior, Animal; Brain; Cognition Disorders; Diabetes Mellitus, Type 2; Diet, High-Fat; Dipeptidyl-Peptidase IV Inhibitors; Hippocampus; Insulin Resistance; Male; Maze Learning; Memory; Memory Disorders; Mitochondria; Nitriles; Obesity; Oxidative Stress; Pyrazines; Pyrrolidines; Rats; Rats, Wistar; Sitagliptin Phosphate; Triazoles; Vildagliptin | 2013 |
Adenosine A(2A) receptors are necessary and sufficient to trigger memory impairment in adult mice.
Topics: Adenosine; Animals; Avoidance Learning; Dose-Response Relationship, Drug; Infusions, Intraventricular; Locomotion; Male; Maze Learning; Memory Disorders; Memory, Short-Term; Mice; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Pyrimidines; Receptor, Adenosine A1; Receptor, Adenosine A2A; Recognition, Psychology; Scopolamine; Triazoles; Xanthines | 2015 |
Source memory in rats is impaired by an NMDA receptor antagonist but not by PSD95-nNOS protein-protein interaction inhibitors.
Topics: Aminosalicylic Acids; Animals; Benzylamines; Cells, Cultured; Chlorophenols; Cyclic GMP; Disease Models, Animal; Disks Large Homolog 4 Protein; Dizocilpine Maleate; Embryo, Mammalian; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Hippocampus; Intracellular Signaling Peptides and Proteins; Male; Maze Learning; Membrane Proteins; Memory Disorders; N-Methylaspartate; Neurons; Nitric Oxide Synthase Type I; Rats; Rats, Long-Evans; Triazoles | 2016 |
Novel tacrine-1,2,3-triazole hybrids: In vitro, in vivo biological evaluation and docking study of cholinesterase inhibitors.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Butyrylcholinesterase; Cell Death; Cell Line; Cell Line, Tumor; Cholinesterase Inhibitors; Humans; Kinetics; Male; Memory Disorders; Molecular Docking Simulation; Neurons; Neuroprotective Agents; Rats; Rats, Wistar; Structure-Activity Relationship; Tacrine; Triazoles | 2017 |
Caffeine and an adenosine A(2A) receptor antagonist prevent memory impairment and synaptotoxicity in adult rats triggered by a convulsive episode in early life.
Topics: Adenosine A2 Receptor Antagonists; Analysis of Variance; Animals; Animals, Newborn; Caffeine; Disease Models, Animal; Disease Progression; Drug Administration Schedule; Glial Fibrillary Acidic Protein; Kainic Acid; Memory Disorders; Neurotoxicity Syndromes; Phosphodiesterase Inhibitors; Purines; Pyrimidines; Qa-SNARE Proteins; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Seizures; Synapses; Synaptophysin; Synaptosomal-Associated Protein 25; Triazoles; Tritium; Xanthines | 2010 |
Adenosine A2A receptor blockade prevents synaptotoxicity and memory dysfunction caused by beta-amyloid peptides via p38 mitogen-activated protein kinase pathway.
Topics: Adenosine A2 Receptor Antagonists; Alzheimer Disease; Amyloid beta-Peptides; Animals; Caffeine; Cell Survival; Cells, Cultured; Down-Regulation; Male; Maze Learning; Memory Disorders; Mice; Mice, Inbred C57BL; Mice, Knockout; Nerve Degeneration; Neuroprotective Agents; p38 Mitogen-Activated Protein Kinases; Peptide Fragments; Phosphodiesterase Inhibitors; Phosphorylation; Presynaptic Terminals; Pyrimidines; Rats; Rats, Wistar; Receptor, Adenosine A2A; Synaptic Membranes; Triazoles | 2009 |
Long-term inhibition of dipeptidyl peptidase-4 in Alzheimer's prone mice.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Brain; Dipeptidyl-Peptidase IV Inhibitors; Glucagon-Like Peptide 1; Memory Disorders; Mice; Mice, Transgenic; Motor Activity; Pyrazines; Sitagliptin Phosphate; Triazoles | 2010 |
Reversal of ketamine-induced working memory impairments by the GABAAalpha2/3 agonist TPA023.
Topics: Animals; Behavior, Animal; Dose-Response Relationship, Drug; Drug Interactions; GABA-A Receptor Agonists; Ketamine; Macaca mulatta; Memory Disorders; Memory, Short-Term; Pyridazines; Triazoles | 2010 |
Endocrine therapy is associated with low performance on some estrogen-sensitive cognitive tasks in postmenopausal women with breast cancer.
Topics: Aged; Anastrozole; Breast Neoplasms; Case-Control Studies; Cognition Disorders; Estrogen Antagonists; Fatigue; Female; Humans; Memory Disorders; Middle Aged; Mood Disorders; Neuropsychological Tests; Nitriles; Postmenopause; Statistics, Nonparametric; Surveys and Questionnaires; Tamoxifen; Triazoles | 2010 |
Protective effect of caffeine and a selective A2A receptor antagonist on impairment of memory and oxidative stress of aged rats.
Topics: Adenosine A2 Receptor Antagonists; Aging; Animals; Ascorbic Acid; Brain; Caffeine; Male; Memory; Memory Disorders; Oxidative Stress; Pyrimidines; Rats; Rats, Wistar; Reactive Nitrogen Species; Reactive Oxygen Species; Sodium-Potassium-Exchanging ATPase; Triazoles | 2011 |
Enhanced role of adenosine A(2A) receptors in the modulation of LTP in the rat hippocampus upon ageing.
Topics: Adenosine; Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Antagonists; Aging; Animals; Electrophysiology; Excitatory Postsynaptic Potentials; Glutamic Acid; Hippocampus; Long-Term Potentiation; Male; Memory Disorders; N-Methylaspartate; Neuronal Plasticity; Pyrimidines; Rats; Rats, Wistar; Receptor, Adenosine A1; Receptor, Adenosine A2A; Synaptic Transmission; Triazoles; Xanthines | 2011 |
A novel glycine transporter-1 (GlyT1) inhibitor, ASP2535 (4-[3-isopropyl-5-(6-phenyl-3-pyridyl)-4H-1,2,4-triazol-4-yl]-2,1,3-benzoxadiazole), improves cognition in animal models of cognitive impairment in schizophrenia and Alzheimer's disease.
Topics: Administration, Oral; Alzheimer Disease; Animals; Brain; Cognition Disorders; Disease Models, Animal; Dizocilpine Maleate; Dose-Response Relationship, Drug; Female; Glycine Plasma Membrane Transport Proteins; Humans; Inhibitory Concentration 50; Male; Memory Disorders; Mice; Oxadiazoles; Permeability; Rats; Rats, Wistar; Schizophrenia; Triazoles | 2012 |
Assessment of the effects of NS11394 and L-838417, α2/3 subunit-selective GABA(A) [corrected] receptor-positive allosteric modulators, in tests for pain, anxiety, memory and motor function.
Topics: Allosteric Regulation; Analgesics; Animals; Anxiety; Benzimidazoles; Disease Models, Animal; Dose-Response Relationship, Drug; Fear; Fluorobenzenes; GABA-A Receptor Agonists; Male; Maze Learning; Memory Disorders; Motor Activity; Pain; Rats; Rats, Wistar; Receptors, GABA-A; Triazoles | 2012 |
Blockade of adenosine A2A receptors reverses short-term social memory impairments in spontaneously hypertensive rats.
Topics: Adenosine A2 Receptor Antagonists; Analysis of Variance; Animals; Caffeine; Discrimination Learning; Habituation, Psychophysiologic; Male; Memory Disorders; Memory, Short-Term; Rats; Rats, Inbred SHR; Rats, Wistar; Receptor, Adenosine A2A; Recognition, Psychology; Smell; Social Behavior; Social Environment; Species Specificity; Triazines; Triazoles; Xanthines | 2005 |
Potentiation of ethanol in spatial memory deficits induced by some benzodiazepines.
Topics: Animals; Azepines; Benzodiazepines; Dose-Response Relationship, Drug; Drug Synergism; Ethanol; Male; Maze Learning; Memory Disorders; Mice; Space Perception; Spatial Behavior; Triazolam; Triazoles | 2006 |
Anastrozole improved testosterone-induced impairment acquisition of spatial learning and memory in the hippocampal CA1 region in adult male rats.
Topics: Analysis of Variance; Anastrozole; Animals; Aromatase Inhibitors; Discrimination Learning; Escape Reaction; Estradiol; Hippocampus; Male; Maze Learning; Memory Disorders; Microinjections; Nitriles; Rats; Rats, Wistar; Reaction Time; Spatial Behavior; Statistics, Nonparametric; Testosterone; Triazoles | 2006 |
Adenosine A2A receptor blockade prevents memory dysfunction caused by beta-amyloid peptides but not by scopolamine or MK-801.
Topics: Adenosine A2 Receptor Antagonists; Amyloid beta-Peptides; Analysis of Variance; Animals; Behavior, Animal; Dizocilpine Maleate; Drug Interactions; Male; Maze Learning; Memory Disorders; Motor Activity; Neuroprotective Agents; Peptide Fragments; Purines; Pyrimidines; Rats; Rats, Wistar; Scopolamine; Triazoles | 2008 |
Chronic postinjury administration of MDL 26,479 (Suritozole), a negative modulator at the GABAA receptor, and cognitive impairment in rats following traumatic brain injury.
Topics: Animals; Brain Injuries; Drug Administration Schedule; Male; Memory; Memory Disorders; Parasympathetic Nervous System; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Space Perception; Time Factors; Triazoles | 1995 |